Efficacy of Tamsulosin in Medical Management of Lower Ureteric Calculi: A Randomized Study

Authors

  • Dr. K S. Shahi Government Medical college Haldwani Nainital Uttarakhand
  • Dr. Geeta Bhandari Govt. medical college haldwani
  • Dr. P. C. sharma govt. medcali. college haldwani

Keywords:

Ureter, calculus, tamsulosin, ?1 adrenergic antagonist, medical expulsion therapy

Abstract

This study was conducted to assess the efficacy of Tamsulosin (α1,adrenergic antagonist) in the management of lower ureteric calcului. Sixty patients of lower ureteric calculus (solitary) were randomly divided in two groups: Group I (Tamsulosin ) n = 30 and Group II (Placebo ) n = 30. Group I received Tamsulosin 0.4 mg (Veltam® – Intas Pharma) plus Diclofenac (Voveran®) 75 mg on demand, group II received placebo (Vit-B-complex) plus Diclofenac 75 mg on demand. Results were analyzed statistically. Average stone size was between 5.96 and 6.08 mm in group I and II respectively. Expulsion rate was 90% in group I and 60 % in group II. Spontaneous expulsion beyond four weeks was 6.6% in group I and 10% in group II. Mean duration of expulsion was 7.87 and 18.47 days in group I and II respectively. Medical expulsion therapy with Tamsulosin is effective in management of lower ureteric calculus of size up to 7 mm.

Author Biographies

  • Dr. K S. Shahi, Government Medical college Haldwani Nainital Uttarakhand
    asso. prof. surgery
  • Dr. Geeta Bhandari, Govt. medical college haldwani
    anesthesiology asso. prof.
  • Dr. P. C. sharma, govt. medcali. college haldwani
    senior resident  surgery

Downloads

Published

2012-06-18

Issue

Vol. 1 No. 1 (2012)

Section

Review Articles

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is notpublished already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  • I/We also agree to the authorship of the article in the following order:

Author’s name

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.